News | April 26, 2025
Zydus Lifesciences to acquire 85.6 % stake in Amplitude Surgical
The closing of the Block Acquisition is now expected to be completed by Q3 2025
The closing of the Block Acquisition is now expected to be completed by Q3 2025
The company has received final approval from the Department of Pharmaceuticals, Government of India, for foreign investment under applicable regulations
Over 1500 stakeholders representing food businesses, packaging industries, recycling associations, regulatory bodies, environmental organizations, consumer groups, farmer groups, government departments participated in the consultation
Zydus MedTech gets rights to market the innovative Transcatheter Aortic Valve Implantation (TAVI) technology in India, Europe and other select markets
The merged entity ‘Aster DM Quality Care’ will be jointly controlled by Aster Promoters and Blackstone
Expanded US manufacturing and R&D presence with investment in 10 facilities, including 7 brand new facilities
David joins HCTI with a distinguished career of over 22 years of corporate finance experience
This approval marks a significant milestone in OneSource’s ongoing commitment to quality and regulatory compliance
In light of the contributions of these three institutes, it was decided to organize a CSIR Startup Conclave in Hyderabad. The event, scheduled for April 22–23, 2025
Approval brings AstraZeneca and Daiichi Sankyo’s Enhertu earlier in the treatment of HR-positive, HER2-low breast cancer and broadens the eligible patient population to those with HER2-ultralow disease
Subscribe To Our Newsletter & Stay Updated
